With the term “oncological screening”, we define the overall performances made to detect
early onset of tumors. These tests are conducted on a population that does not have any …

The policy recommends cytology-based screening every three years from 25 to 30 years of
age, followed by HPV-based screening every five years from 30 to 65 years of age (Exhibit …

Background: Squamous intraepithelial lesions observed in Papanicolaou (Pap) test
gynecologic cytology arise as a result of infection of the cervicovaginal tract by human …

Objective To assess the impact of recently published American Society of Cytopathology
(ASC) guidelines (2017) on the conduct of cervical cytology‐histology correlation (CHC) …

The author was the chair of a College of American Pathologists working group at the
Gynecologic Cytopathology Quality Consensus Conference outlining then current practices …

The baseline data from the private-based opportunistic cervical cancer screening with
HRHPV14, liquid-based cytology (LBC) and p16/Ki67 testing, and its quality …

Recent evidence suggests that a cytology–histology correlation (CHC) with discrepancy
detection can both evaluate errors and improve the sensitivity and specificity of the cytologic …

Introduction Fine-needle aspiration biopsy (FNAB) plays a critical role in the management of
patients with salivary gland lesions. A specific diagnosis can be difficult due to the wide …

Context.—The College of American Pathologists (CAP) updated the Laboratory
Accreditation Program Cytopathology Checklist to assist laboratories in meeting and …

BACKGROUND Cervical cancer screening in China is largely limited to occasional
opportunistic screening in urban centers. The current study reports histopathologic follow‐up …